ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for schizophrenia and Alzheimer's psychosis enters early human testing
Symptom relief Recruiting nowThis early-stage study tests a new extended-release tablet called LY03020 in healthy adults and people with stable schizophrenia. The main goal is to check safety and how the body processes the drug. About 40 participants will receive either the drug or a placebo, and researchers…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated May 17, 2026 08:20 UTC
-
New hope for Alzheimer's psychosis: drug trial targets hallucinations
Symptom relief Recruiting nowThis study tests an experimental drug called ACP-204 to see if it can reduce hallucinations and delusions in people with Alzheimer's disease psychosis. About 1,074 adults aged 55 to 95 will receive either the drug or a placebo for 6 weeks. The goal is to improve symptoms without …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 05, 2026 11:52 UTC